Article

From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.

Department of Experimental and Applied Medicine, Section of Occupational Health and Industrial Hygiene, University of Brescia, Brescia, Italy.
Neuromolecular medicine (Impact Factor: 3.89). 12/2009; 11(4):311-21. DOI: 10.1007/s12017-009-8108-8
Source: PubMed

ABSTRACT Manganism is a distinct medical condition from Parkinson's disease. Manganese exposure scenarios in the last century generally have changed from the acute, high-level exposure conditions responsible for the occurrence of manganism to chronic exposure to much lower levels. Such chronic exposures may progressively extend the site of manganese deposition and toxicity from the globus pallidus to the entire area of the basal ganglia, including the substantia nigra pars compacta involved in Parkinson's disease. The mechanisms of manganese neurotoxicity from chronic exposure to very low levels are not well understood, but promising information is based on the concept of susceptibility that may place individuals exposed to manganese at a higher risk for developing Parkinsonian disturbances. These conditions include mutations of genes which play important pathogenetic roles in both Parkinsonism and in the regulation of manganese transport and metabolism. Liver function is also important in manganese-related neurotoxicity and sub-clinical impairment may increase the risk of Parkinsonism. The purpose and scope of this report are to explore the literature concerning manganese exposure and potential subclinical effects and biological pathways, impairment, and development of diseases such as Parkinsonism and manganism. Inhalation and ingestion of manganese will be the focus of this report.

Download full-text

Full-text

Available from: Roberto Lucchini, Jun 26, 2015
1 Follower
 · 
328 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nowadays more than thousands of different nanoparticles are known, though no well-defined guidelines to evaluate their potential toxicity and to control their exposure are fully provided. The way of entry of nanoparticles together with their specificities such as chemistry, chemical composition, size, shape or morphology, surface charge and area can influence their biological activities and effects. A specific property may give rise to either a safe particle or to a dangerous one. The small size allows nanoparticles to enter the body by crossing several barriers, to pass into the blood stream and lymphatic system from where they can reach organs and tissues and strictly interact with biological structures, so damaging their normal functions in different ways. This review provides a summary of what is known on the toxicology related to the specificity of nanoparticles, both as technological tools or ambient pollutants. The aim is to highlight their potential hazard and to provide a balanced update on all the important questions and directions that should be focused in the near future.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mangan (Mn) ist seit mittlerweile 175 Jahren als neurotoxische Substanz bekannt. Daher ist es im Lauf des letzten Jahrhunderts intensiv erforscht worden. Von vorläufigen Beschreibungen ausschließlich über Symptomen bei Mn-exponierten bzw. überexponierten Arbeitern sind die Forschungsarbeiten zu detaillierteren Untersuchungen der toxischen Mechanismen von Mn fortgeschritten. Zur Aufklärung dieser neurotoxischen Mechanismen wurde eine Reihe von Studien durchgeführt, die z. T. in Übersichtsartikeln zusammengefasst wurden (z. B. Yokel RA. Neuromol Med 2009;11(4):297–310; Aschner M et al. Toxicology Appl Pharmacol 2007;221(2):131–47; Michalke B et al. J Environ Monit 2007;9(7):650). Seit unserem letzten Übersichtsartikel zur Mn-Speziation aus dem Jahr 2007 (Michalke B et al. J Environ Monit 2007;9(7):650) ist die Mn-Forschung beträchtlich vorangetrieben worden, und es sind mehrere neue Forschungsartikel erschienen. In den letzten Jahren fächerte sich jedoch die Erforschung der Mn-Toxizität in verschiedene Felder auf, wobei sehr detaillierte und komplexe Studiendesigns angewendet wurden. Insbesondere die Mechanismen der Mn-induzierten Nervenschädigung auf zellulärer und molekularer Ebene wurden genauer untersucht. Diskutiert wurden dabei Wechselwirkungen zwischen Neurotransmittern und Enzymen, Wirkmechanismen auf DNA-Ebene und auch die Einbeziehung genetischer Einflüsse. Ein wichtiges Thema war auch die Beschreibung spezieller Mn-Spezies, um so zu ermitteln, welches Molekül Mn an der Zellmembran transportiert und welches für die Schädigung des neuronalen Gewebes verantwortlich ist. Auch andere spezielle Schwerpunkte wie epidemiologische Studien wurden zunehmend wichtiger: Die betreffenden Arbeiten befassten sich mit Umwelteinflüssen von Mn insbesondere auf die Prävalenz der Parkinson-Krankheit sowie die Möglichkeit, Follow-up-Studien zur lebenslangen Exposition gegenüber Mn durchzuführen. Alle diese weit ausgreifenden Forschungsansätze können letztendlich dazu beitragen, mithilfe eines geeigneten Bio-Monitorings am Menschen in Zukunft das frühe Einsetzen von Manganismus zu verhindern oder zumindest rechtzeitig zu erkennen.
    01/2013; 2(1-4). DOI:10.1016/j.permed.2013.12.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The World Health Organization (WHO) released the fourth edition of Guidelines for Drinking-Water Quality in July 2011. In this edition, the 400-µg/L drinking-water guideline for manganese (Mn) was discontinued with the assertion that because "this health-based value is well above concentrations of manganese normally found in drinking water, it is not considered necessary to derive a formal guideline value." In this commentary, we review the WHO guideline for Mn in drinking water--from its introduction in 1958 through its discontinuation in 2011. For the primary references, we used the WHO publications that documented the Mn guidelines. We used peer-reviewed journal articles, government reports, published conference proceedings, and theses to identify countries with drinking water or potential drinking-water supplies exceeding 400 µg/L Mn and peer-reviewed journal articles to summarize the health effects of Mn. Drinking water or potential drinking-water supplies with Mn concentrations > 400 µg/L are found in a substantial number of countries worldwide. The drinking water of many tens of millions of people has Mn concentrations > 400 µg/L. Recent research on the health effects of Mn suggests that the earlier WHO guideline of 400 µg/L may have been too high to adequately protect public health. The toxic effects and geographic distribution of Mn in drinking-water supplies justify a reevaluation by the WHO of its decision to discontinue its drinking-water guideline for Mn.
    Environmental Health Perspectives 02/2012; 120(6):775-8. DOI:10.1289/ehp.1104693 · 7.03 Impact Factor